2dd663f94c534bcda02a8e1b8c5a011e3bcd64a58a80412585b42c68976f3e5c3f81569c399e48c8afbb3c0a9f503fbc74f0b1697a284edfac489f12e418ab0177c1f745a0f0446ca81b89b8dbc3747fa953f3ddf3f943198b40e3eeebcc604dacddc39400ed4be197695f6528e550b5aea6819c93024237b9650d273616472cb430f337c0c7419588ce7f4119615122c0ec323d8dd247b88e12730452cc120cf94193676104434798b6bd0a651b1938
agent
Developing a potentially immunologically inert tetracycline-regulatable viral vector for gene therapy in the peripheral nerveClinical and neurobiological advances in promoting regeneration of the ventral root avulsion lesionNerve surgery and gene therapy: a neurobiological and clinical perspective.Lentiviral vector-mediated gradients of GDNF in the injured peripheral nerve: effects on nerve coil formation.The Chemorepulsive Protein Semaphorin 3A and Perineuronal Net-Mediated PlasticityThe chemorepulsive axon guidance protein semaphorin 3A is a constituent of perineuronal nets in the adult rodent brain.Gene delivery to rat and human Schwann cells and nerve segmentsGene therapy approaches to enhance regeneration of the injured peripheral nerve.A comparative morphological, electrophysiological and functional analysis of axon regeneration through peripheral nerve autografts genetically modified to overexpress BDNF, CNTF, GDNF, NGF, NT3 or VEGFCharacterization of glial cell models and in vitro manipulation of the neuregulin1/ErbB systemALS as a distal axonopathy
author
nationality
type
label
F. De Winter